Ocumension Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	458.06	769.21	1,054	1,314	1,785	2,052
Trading Asset Securities	120.21	-	-	-	-	-
Cash & Short-Term Investments	578.27	769.21	1,054	1,314	1,785	2,052
Cash Growth	-40.56%	-27.01%	-19.83%	-26.37%	-12.99%	64.39%
Accounts Receivable	149.81	164.07	119.36	112.71	18.51	7.81
Other Receivables	23.19	-	-	-	25.84	40.75
Receivables	173	164.07	119.36	112.71	44.35	48.56
Inventory	66.42	45.52	32.47	24.1	4.99	3.03
Other Current Assets	-	-	-	3.9	-	-
Total Current Assets	817.69	978.8	1,206	1,455	1,835	2,103
Property, Plant & Equipment	468.4	451.53	467.65	448.07	365.86	82.03
Long-Term Investments	13.93	12.93	364.15	95	272.4	-
Other Intangible Assets	2,494	2,438	1,140	919.05	709.97	25.78
Long-Term Deferred Charges	-	-	-	-	-	175.88
Other Long-Term Assets	102.96	92.43	93.39	126.4	148.25	212.48
Total Assets	3,897	3,974	3,271	3,044	3,331	2,600
Accounts Payable	11.74	34.42	25.19	21.7	4.41	9.34
Accrued Expenses	88.21	82.27	100.35	140.94	89.04	13.23
Short-Term Debt	-	-	120	-	-	-
Current Portion of Long-Term Debt	10.44	2.06	-	-	-	-
Current Portion of Leases	11.93	6.84	12.33	12.29	4.19	1.93
Current Income Taxes Payable	0.29	1.04	0.34	1.55	2.4	1.44
Current Unearned Revenue	5.04	7.59	9.05	-	-	-
Other Current Liabilities	27.02	20.79	48.02	71.18	115.82	65.99
Total Current Liabilities	154.67	155	315.28	247.65	215.85	91.93
Long-Term Debt	38.53	14.49	-	-	-	-
Long-Term Leases	22.33	2.39	5.66	17.29	7.03	5.31
Long-Term Unearned Revenue	28.3	28.3	30.09	30.09	-	-
Total Liabilities	243.82	200.19	351.03	295.04	222.88	97.23
Common Stock	0.06	0.06	0.05	0.05	0.05	0.04
Additional Paid-In Capital	8,888	8,844	7,626	7,511	7,355	6,546
Retained Earnings	-5,003	-4,876	-4,722	-4,447	-4,045	-3,785
Treasury Stock	-0	-0	-0	-0	-0	-0
Comprehensive Income & Other	-232.32	-194.51	15.95	-315.8	-202.79	-258.69
Total Common Equity	3,653	3,774	2,920	2,749	3,108	2,502
Shareholders' Equity	3,653	3,774	2,920	2,749	3,108	2,502
Total Liabilities & Equity	3,897	3,974	3,271	3,044	3,331	2,600
Total Debt	83.22	25.78	137.98	29.58	11.21	7.24
Net Cash (Debt)	495.05	743.42	915.82	1,285	1,774	2,045
Net Cash Growth	-48.30%	-18.82%	-28.72%	-27.57%	-13.23%	-
Net Cash Per Share	0.66	1.09	1.41	2.03	2.92	6.76
Filing Date Shares Outstanding	813.83	815.73	690.66	688.74	618.42	591.14
Total Common Shares Outstanding	813.83	815.73	690.66	688.74	618.42	591.14
Working Capital	663.02	823.79	890.35	1,208	1,619	2,011
Book Value Per Share	4.49	4.63	4.23	3.99	5.03	4.23
Tangible Book Value	1,159	1,335	1,780	1,830	2,398	2,477
Tangible Book Value Per Share	1.42	1.64	2.58	2.66	3.88	4.19
Machinery	-	394.82	383.13	93.79	10.1	6.84
Construction In Progress	-	93.56	86.22	323.86	336.98	59.03
Leasehold Improvements	-	15.21	13.49	9.55	3.61	2.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.